- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 227.76M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $244M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $241M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $263M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $261M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $686M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $740M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.94B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.85B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.91B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.55B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $953M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $990M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.48B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.15B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 223.43M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $17M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$22M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $484M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $507M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$26M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $865M |